Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers

Manyara, A. M. , Ciani, O. and Taylor, R. S. (2022) Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers. Alzheimer's and Dementia, 8(1), e12344. (doi: 10.1002/trc2.12344)

[img] Text
274865.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

124kB

Abstract

No abstract available.

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Ciani, Professor Oriana and Manyara, Dr Anthony and Taylor, Professor Rod
Authors: Manyara, A. M., Ciani, O., and Taylor, R. S.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > General Practice and Primary Care
College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > MRC/CSO SPHSU
College of Social Sciences > School of Social and Political Sciences
Journal Name:Alzheimer's and Dementia
Publisher:Wiley
ISSN:1552-5260
ISSN (Online):1552-5279
Published Online:25 July 2022
Copyright Holders:Copyright © 2022 The Authors
First Published:First published in Alzheimer's and Dementia 8(1):e12344
Publisher Policy:Reproduced under a Creative Commons licence

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
313399Reporting of randomised trials using surrogate outcomes: development of extensions to the CONSORT 2010 and SPIRIT 2013 guidance statementsRodney Stephen TaylorMedical Research Council (MRC)MR/V038400/1HW - MRC/CSO Social and Public Health Sciences Unit